Why is Jagsonpal Pharma falling/rising?

As of 12-Sep, Jagsonpal Pharmaceuticals Ltd's stock price is currently at Rs 241.70, reflecting a decrease of Rs 6.7 or 2.7%. Today's price summary indicates that the stock has underperformed its sector by 2.99% and has experienced a trend reversal after two consecutive days of gains. Although the stock opened with a gain of 2.09% and reached an intraday high of Rs 253.6, it also touched a low of Rs 239.25 during the day. Over the past week, the stock has shown a slight increase of 0.21%, but it has declined by 2.44% over the past month. Despite this recent downturn, the company has demonstrated healthy long-term growth, with a significant annual operating profit increase of 42.31% and positive results for the last five consecutive quarters, which may support its overall valuation.
In the broader market context, the stock's performance over the past week is notably weaker than the benchmark Sensex, which has gained 1.48% in the same period. Year-to-date, Jagsonpal Pharmaceuticals has underperformed with a decline of 1.13%, while the Sensex has risen by 4.82%. However, the stock has outperformed the benchmark over longer periods, including a 49.31% increase over the past year and a remarkable 1609.34% rise over the past five years. This long-term outperformance may provide some resilience against short-term fluctuations, but the recent price drop suggests that investors are reacting to immediate market conditions and performance metrics.